CLINICAL_TRIALS ClinicalTrials.gov record update

Open-label,Non-randomised,Multicentre,Phase I Study to Assess the Pharmacokinetics, Safety & Tolerability of Osimertinib Following a Single Oral 80mg Dose to Patients w/ Adv Solid Tumours & Normal Renal Function or Severe Renal Impairment.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02923947
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:26.993670+00:00
Published At: 2023-11-27T00:00:00+00:00
Record Updated At: 2023-11-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Tumours"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-11-27"
protocolSection.identificationModule.nctId: "NCT02923947"
protocolSection.identificationModule.officialTitle: "Open-label,Non-randomised,Multicentre,Phase I Study to Assess the Pharmacokinetics, Safety \u0026 Tolerability of Osimertinib Following a Single Oral 80mg Dose to Patients w/ Adv Solid Tumours \u0026 Normal Renal Function or Severe Renal Impairment."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.